These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 26956954)
1. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure. Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study. Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210 [TBL] [Abstract][Full Text] [Related]
3. Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure. Laliberte B; Reed BN; Devabhakthuni S; Watson K; Ivaturi V; Liu T; Gottlieb SS J Card Fail; 2017 Oct; 23(10):746-752. PubMed ID: 28688888 [TBL] [Abstract][Full Text] [Related]
5. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure. Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767 [TBL] [Abstract][Full Text] [Related]
6. Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study. Wu D; Ma Z; Wang X; Wang X; Wang X BMC Cardiovasc Disord; 2024 Aug; 24(1):402. PubMed ID: 39090542 [TBL] [Abstract][Full Text] [Related]
7. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure. Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699 [TBL] [Abstract][Full Text] [Related]
8. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study. Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146 [TBL] [Abstract][Full Text] [Related]
9. The impact of the first 24 h of loop diuretic on kidney function in acute decompensated heart failure. Alshibani M; Alshehri S; Bakhaider A; Atbani A; Ismail M; Jazzar B; Eljaaly K; Althagafi A; Aljabri A Ir J Med Sci; 2021 Aug; 190(3):987-992. PubMed ID: 33222077 [TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181 [TBL] [Abstract][Full Text] [Related]
11. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131 [TBL] [Abstract][Full Text] [Related]
12. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure. Barsuk JH; Gordon RA; Cohen ER; Cotts WG; Malkenson D; Yancy CW; Williams MV Congest Heart Fail; 2013; 19(2):53-60. PubMed ID: 23336425 [TBL] [Abstract][Full Text] [Related]
13. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure. Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739 [TBL] [Abstract][Full Text] [Related]
15. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
16. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge. Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159 [TBL] [Abstract][Full Text] [Related]
17. Diuretics and ultrafiltration in acute decompensated heart failure. Felker GM; Mentz RJ J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934 [TBL] [Abstract][Full Text] [Related]
18. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure. Aoki S; Okumura T; Sawamura A; Kitagawa K; Morimoto R; Sakakibara M; Murohara T Am J Cardiol; 2017 Jun; 119(12):2010-2016. PubMed ID: 28438307 [TBL] [Abstract][Full Text] [Related]
20. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure. Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]